As we emerge from COVID-19’s dark shadow, the pandemic is serving as a broad catalyst for change in consumer expectations and a reordering of work, business and the economy. The US health care system sits at the center of COVID’s reckoning and newly added urgency for lasting change. Inequities in access to care and the enormous challenges in caring for the persistently ill are top priorities as government and stakeholders explore the public health “lessons learned.”
Join a discussion with Michael Chernew to explore how COVID can catalyze innovation to pay for the expanded medical care with fresh thinking about restraining the cost of treatment that supplies little or no value. Chernew argues that we should be pulling back from the models of care coordination and disease management that enjoy strong followings in favor of more targeted approaches that will deliver more effective cost control.